KAERI Develops Zr-89 Production Device

The Korea Atomic Energy Research Institute said this week it had developed a device to produce two pharmaceutical isotopes including Zr-89, which has a half-life of 3.3 days, making it one of the longer-lasting isotopes that extends options for viable cancer diagnosing.(read more)